JFJoyce Godoy Farat

Joyce Godoy Farat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joyce Godoy Farat has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Eliane Chaves Jorge

    Department of Surgical Specialties and Anesthesiology (Ophthalmology Division), Botucatu Medical School, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil

    1 shared publication
  • Felipe Gasparini dos Santos

    Department of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista "Julio de Mesquita Filho", Botucatu, SP, Brazil

    1 shared publication
  • Regina El Dib

    Institute of Science and Technology, Universidade Estadual Paulista, São José dos Campos, SP, Brazil

    1 shared publication
  • Roberta Lilian Fernandes de Sousa Meneghim

    Department of Ophthalmology, Faculdade de Medicina, Universidade Estadual Paulista "Júlio de Mesquita Filho", Botucatu, SP, Brazil

    1 shared publication
  • Silvana Artioli Schellini

    Department of Ophthalmology, Faculdade de Medicina, Universidade Estadual Paulista "Júlio de Mesquita Filho", Botucatu, SP, Brazil

    1 shared publication

Latest Publications

  • Open Access

    Probing for congenital nasolacrimal duct obstruction: a systematic review and meta-analysis of randomized clinical trials

    by Joyce Godoy Farat, Silvana Artioli Schellini, Regina El Dib, Felipe Gasparini dos Santos, Roberta Lilian Fernandes Sousa Meneghim, Eliane Chaves Jorge

    Purpose: Lacrimal probing is the treatment of choice for congenital nasolacrimal duct obstruction that does not have a spontaneous resolution; however, there is no consensus about the best time for probing and if it is superior to other therapies. The present study aimed to evaluate the effectiveness of lacrimal probing compared with other treatments/no intervention to treat congenital nasolacrimal duct obstruction. Methods: A systematic review of literature in PubMed, EMBASE, CENTRAL, clinicaltrials.gov, and LILACS databases up to December 2019 was performed. Randomized clinical trials that enrolled children diagnosed with congenital nasolacrimal duct obstruction and undergoing lacrimal probing were considered. Data extraction and a risk of bias assessment were conducted independently and in duplicate. The overall quality of evidence for each outcome was conducted using the Grading of Recommendations, Assessment, Development, and Evaluation classification system. Results: Four randomized clinical trials involving 423 participants were eligible. No statistically significant differences were observed in resolution rates between early probing and observation/late probing (two studies; risk ratio 1.00 [95% confidence interval 0.76-1.33]; p=0.99; low certainty evidence). One study reported better resolution rates with bicanalicular silicone stent intubation compared with late probing in the complex congenital nasolacrimal duct obstruction cases subgroup (risk ratio 0.56 [95% confidence interval 0.34-0.92]; p=0.02; moderate certainty evidence). Conclusions: Low certainty evidence suggests that early probing has the same success rate as late probing. Evidence of moderate certainty suggests that late probing has a lower success rate than bicanalicular silastic intubation in patients with complex congenital nasolacrimal duct obstructione.